Graves Disease
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
This study was designed to unveil the association of GPR174 rs3827440, PTPN22 rs3789604, and RNASET2 rs9355610 with the onset of liver damage (LD) among the Graves' disease (GD) patients.
|
28568286 |
2018 |
Graves Disease
|
0.320 |
Biomarker
|
disease |
CTD_human |
A genome-wide association study identifies two new risk loci for Graves' disease.
|
21841780 |
2011 |
Hyperthyroidism
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The C allele of rs3789604 (PTPN22) was a significant risk factor for LD-associated hyperthyroidism in GD patients, whereas C allele of GPR174 rs3827440 and G allele of RNASET2 rs9355610 appeared to be a protective factor for this disease.
|
28568286 |
2018 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, the vulnerability of the knockout rat hippocampus as evidenced by neuroinflammation, altered lysosomal function and cognitive defects indicates that this is still a useful <i>in vivo</i> model to study RNASET2 function.
|
29752287 |
2018 |
Inflammatory Bowel Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
RNASET2 was the only IBD risk-associated gene with >5-fold down-regulation in the IFNG-secreting subset.
|
28400196 |
2017 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Leukodystrophy
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our patients illustrate the clinical and radiological overlap that can be seen between RNASET2-related leukodystrophy and AGS in some cases.
|
27091087 |
2016 |
Leukodystrophy
|
0.020 |
Biomarker
|
disease |
BEFREE |
The clinical data and magnetic resonance imaging (MRI) findings of previous reported individuals with RNASET2-deficient leukodystrophy were also reviewed and compared to the findings of our patient.
|
31349848 |
2019 |
Leukoencephalopathy
|
0.050 |
Biomarker
|
group |
BEFREE |
Defective RNASET2 leads to RNASET2-deficient leukoencephalopathy, a rare autosomal recessive neurogenetic disorder with psychomotor delay as its main clinical symptom.
|
31349848 |
2019 |
Leukoencephalopathy
|
0.050 |
GeneticVariation
|
group |
BEFREE |
Leukoencephalopathy with temporal lobe cysts may be associated with monogenetic conditions such as Aicardi-Goutières syndrome or RNASET2 mutations and with congenital infections such as cytomegalovirus.
|
27843092 |
2017 |
Leukoencephalopathy
|
0.050 |
Biomarker
|
group |
BEFREE |
RNASET2 deficiency in humans is associated with infant cystic leukoencephalopathy, which causes psychomotor impairment, spasticity and epilepsy.
|
29752287 |
2018 |
Leukoencephalopathy
|
0.050 |
GeneticVariation
|
group |
BEFREE |
RNASET2 mutation in humans is linked with a leukoencephalopathy that arises in infancy characterized by cortical cysts and multifocal white matter lesions.
|
21199949 |
2011 |
Leukoencephalopathy
|
0.050 |
GeneticVariation
|
group |
BEFREE |
Here we show that loss-of-function mutations in the gene encoding the RNASET2 glycoprotein lead to cystic leukoencephalopathy, an autosomal recessive disorder with an indistinguishable clinical and neuroradiological phenotype.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A practical approach to diagnosing adult onset leukodystrophies.
|
24357685 |
2014 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
|
25655951 |
2015 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
rnaset2 mutant zebrafish model familial cystic leukoencephalopathy and reveal a role for RNase T2 in degrading ribosomal RNA.
|
21199949 |
2011 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Cystic leukoencephalopathy without megalencephaly is a disorder related in some cases to RNASET2 mutations and characterized by bilateral anterior temporal subcortical cysts and multifocal lobar white matter lesions with sparing of central white matter structures.
|
27091087 |
2016 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Lung Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
|
28604730 |
2017 |
Lymphocyte Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes.
|
22286170 |
2012 |